Effect of local positive pressure therapy for Meniere disease and delayed endolymphatic hydrops.

Effect of local positive pressure therapy for inner ear vertigenous disease - Effect of local positive pressure therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041164

Enrollment

Registered

2020-07-20

Start date

2020-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meniere disease delayed endolymphatic hydrops

Interventions

medications, six months to one year middle ear pressure or surgery, six months to one year

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: recurrent vertigeneous patients, such as Meniere disease and so on.

Exclusion criteria

Exclusion criteria: perforation of ear drum patients woth severe renal disease and asthma.

Design outcomes

Primary

Measure	Time frame
frequency of vertigo attacks volume of endolymphatic hydrops	—

Secondary

Measure	Time frame
auditory and vestibular function	—

Countries

Japan

Contacts

Public ContactMunehisa Fukushima

Kansai Rosai Hospital 660-8511

mfukushima@kansaih.johas.go.jp06-6416-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026